Strs Ohio Kal Vista Pharmaceuticals, Inc. Transaction History

Strs Ohio

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$11.07 - $16.04 $39,852 - $57,744	3,600 New	3,600 $42,000
Q3 2023 Oct 26, 2023	BUY	$8.95 - $11.35 $96,659 - $122,580	10,800 New	10,800 $104,000
Q3 2021 Oct 22, 2021	SELL	$17.11 - $24.49 $222,430 - $318,370	-13,000 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$23.12 - $29.91 $78,608 - $101,694	-3,400 Reduced 20.73%	13,000 $311,000
Q1 2021 Apr 23, 2021	BUY	$14.69 - $42.57 $240,916 - $698,148	16,400 New	16,400 $421,000
Q3 2019 Oct 21, 2019	SELL	$11.6 - $21.67 $35,960 - $67,177	-3,100 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$18.44 - $30.89 $57,164 - $95,759	3,100 New	3,100 $68,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $193M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.